patients, vascular access problems and low volume of blood are important factors.
The collection of PBSC requires venous access which We analyzed the use of non-tunneled (polyurethane, double lumen) central venous catheters (CVCs) for the ensures withdrawal and reinfusion of blood at high flow rates and allows repeated leukapheresis. The majority of collection, conditioning, transplantation and immediate post-transplantation periods in 56 children with various child candidates for PBSCT do not have adequate peripheral veins for collection. A central venous catheter is theremalignant diseases. A total of 71 leukaphereses were performed, with a mean of 1.2 apheresis per patient, fore required at least for withdrawal of blood. 8 Here, we analyze our experience of collection procedures following administration of granulocyte colonystimulating factor (G-CSF) using a continuous flow performed with non-tunneled catheters in pediatric patients. These catheters were used for collection, during conditionblood cell separator (Cobe Spectra). The mean TBV (total blood volume) processed was 4.5 ؎ 1. 
Complications during conditioning, transplantation and
Patients had the following diagnoses: nine acute lymphoblimmediate post-transplantation periods were entry site astic leukemia (ALL), five acute non-lymphoblastic leukeinfection in five patients (8.92%), catheter-related infecmia (ANLL), six non-Hodgkin's lymphoma (NHL), three tion in two (3.57%) and catheter-related sepsis in three Hodgkin's disease (HD), 10 rhabdomyosarcoma, seven (5.35%). Our results indicate that the collection of neuroblastoma, five Ewing's sarcoma, one Wilm's tumor PBSC with non-tunneled catheters is safe, effective and and 10 central nervous system tumors. Parents and patients is associated with a low incidence of complications.
were provided with information concerning the procedure. Keywords: non-tunneled catheter; PBSC transplantation;
Patient characteristics are summarized in Table 1 . PBSC collection; children Metálicos, Madrid, Spain) and stored in liquid nitrogen at Patients were sedated with propofol (priming dose of 2 −196°C. mg/kg and then continued perfusion of 1-5 mg/kg/h) and fentanest (doses of 1-2 g/kg) and the procedure was perInfection formed in the intensive care unit with monitoring.
All patients had Ͼ50 × l0 9 /l platelets at the time of cathWhen patients developed fever, two urine cultures, one eter insertion and none had abnormal coagulation. The stool culture, one nasopharyngeal smear, two cultures from CVCs used were standard double-lumen, Arrow-Howes central blood (one from each lumen), one peripheral blood (Reading, PA, USA) polyurethane catheters in 41 patients culture, and a chest radiograph (PA and lateral projections) and Cook (Cook, Bjaeverskov, Denmark) polyurethane were taken. catheters in 16.
Entry site infection was defined as pain, induration and The catheter was removed immediately after apheresis erythema. Catheter-related infection was defined as the in those patients in whom transplantation could not be carpresence of fever and shivering after an infusion through ried out immediately. Catheter size was 5 FR for patients the CVC without other apparent causes of infection, and a Ͻ5 years, 7 FR for those aged 5-12 years and 9.5 FR for positive central but not peripheral blood culture. Catheterthose Ͼ12 years, and 15, 20 and 25 cm in length, respectrelated sepsis was defined as the isolation of the same ively. Correct positioning of the catheter was confirmed by pathogen from the CVC and blood culture taken from a a PA chest film before attaching it to the skin with a 3-peripheral vein. The criteria for catheter removal were: (1) 0 nylon suture. No antibiotic prophylaxis was used after local infection in the form of abscess and/or entry site infecthe procedure.
tion; and (2) catheter-related sepsis or infection that did not respond to antibiotic treatment.
PBSC mobilization

Mechanical dysfunction
All the patients received subcutaneous granulocyte colonystimulating factor (G-CSF), dose 12 g/kg/day for 4-5 days Mechanical dysfunction was defined as inadequate flow (Neupogen; Amgen, Thousand Oaks, CA, USA).
rates or failure to withdraw blood. When the foregoing was Leukapheresis was performed on the fifth day.
suspected, the following procedure was adopted: lavage with saline solution +1% heparin (300 IU) and if catheter PBSC collection dysfunction persisted after 15 min, infusion of urokinase (10-15 000 IU). PBSC collections were performed using a Cobe Spectra blood cell separator (Cobe Spectra, Denver, CO, USA) as previously reported. Results the final product by the total number of mononuclear cells that were processed. The total cell count was determined Catheters using an automated cell counter, and the differential cell All patients except one used one catheter for the apheresis. count was performed manually. Mononuclear cells included One required immediate replacement after insertion only lymphocytes and monocytes. Purity of the final probecause of lumen obstruction. In 17 patients (30.3%) the duct refers to the percentage of mononuclear cells accordcatheter was used only for apheresis, and the mean duration ing to the differential cell count.
of insertion was 2 days (range 1-4). In the remaining cases, Cells were labeled with fluorescence conjugated antithe catheter was also used for conditioning, transplantation CD34 (8GI2 CD; Becton Dickinson, Mountain View, CA, and in the immediate post-transplantation period (39 USA) and analyzed using a FACScan flow cytometer patients (70.63%) ) and the mean duration of insertion was (Becton Dickinson) to yield an absolute CD34 + result. 47.9 days (range 5-200). Granulocyte-macrophage progenitor cells (colonyforming unit granulocyte-macrophage, CFU-GM) were analyzed in each apheresis product. Fresh viable peripheral
Progenitor cells collection results blood cells (2 × 10 5 ) were plated in triplicate using semisolid medium. Cultures were incubated and colonies were Seventy-one aphereses were perfomed with a mean of 1.2 aphereses per patient (range 1-3). One patient received scored following standard methods. three aphereses, and 13 patients received two. In all other Discussion patients one collection was performed.
The volume of blood processed in each apheresis ranged The aim of PBSC collection is to obtain an MNC product of high purity. This can be achieved by leukapheresis with from 2209 to 19 370 ml (mean 9746 ml Ϯ 4179.5 s.d. insertion but this did not require drainage and resolved have been utilized, like other authors, we believe that the spontaneously within 2 days. There were two other cases subclavian and femoral veins provide the most simple and with technique-related complications including ectopic safe access. 4, 6, 17 We have chiefly utilized the subclavian puncture or canalization of contralateral vessels. No vein in patients in whom the catheter was also used for hemorrhagic complications were observed.
conditioning, transplantation and the immediate posttransplantation periods since this access allows the catheter to be left in situ for a longer period, with less risk of infecComplications related to apheresis tion. Femoral vein access was used for leukapheresis exclusively in children who were not undergoing immediate Morbidity related to PBSC harvest was minor. Transient transplantation, since this site carries a higher risk of hypotensive episodes were observed at the beginning of infection. apheresis in two children (3.5%) who did not require treat-
The most common complications of non-tunneled inserment. Hypocalcemia attributed to citrate occurred in 10 tion are infection, mechanical dysfunction and mechanical patients (17.5%); of these, eight were asymptomatic. There complications. Pneumothorax and hemopneumothorax are were two cases (3.5%) of mechanical dysfunction that complications specific to this technique. The incidence of resolved with thrombolytic therapy and seven cases (12%) these complications in our series was low (1.7%) and lower required extreme positional maneuvers due to low flow than the complication rate reported by other authors.
18
rates; none required discontinuation of the apheresis proMechanical dysfunction (which resolved in all cases) incicedure. Other minor complications included headache (one dence was 3.5%, which is lower than has been reported patient, 1.7%), low fever (one patient, 1.7%), and nausea elsewhere (10-20%) . 19 This may be due to the use of polyand vomiting (three patients, 5.2%). No profound cytopenia urethane catheters, which are more rigid and have a lower post-apheresis was observed and no child required red cell mechanical dysfunction rate than silicone catheters. 20 or platelet transfusion. Some authors have used the Quinton-Mahurkar largebore hemodialysis catheters, 13 but experience in children is very limited. The catheter utilized in our series achieved a median inlet blood flow of 30.6 ml/min, maintained without Complications during transplantation variation throughout apheresis, and a high purity (77.3%). This is similar to the rate achieved in adults using other We observed a total of 10 infectious complications: entry site infection (five patients, 8.92%), catheter-related infeccatheters. 15 Furthermore, these catheters were utilized for large volume leukapheresis. 7 tion (two patients, 3.57%) and catheter-related sepsis (three patients, 5.35%). Four patients required catheter removal
The numbers of CD34 + cells and MNC obtained with mobilization with G-CSF alone was 6.2 × 10 6 (range 1-42) despite antibiotic therapy.
Pathogens isolated were Staphylococcus epidermidis and 9.8 × 10 8 (range 2-24), respectively, similar to those achieved by other authors using this mobilization tech-(five patients), Staphylococcus aureus (one patient), Staphylococcus hominis (one patient) and Staphylococcus nique. 3, 6, 21 The advantage of using these catheters is that in 39 haemolyticum (one patient).
Six patients had clinical events suggestive of CVC dyspatients the same catheter was used during conditioning, transplantation and the immediate post-transplantation perfunction (10.5%) which resolved with lavage with saline solution plus heparin in three cases, and with urokinase iods, and the discomfort caused by insertion of another catheter avoided. With the single non-tunneled catheter, we infusion in one case. The remaining two cases required catheter removal.
had an entry site infection rate of 8. 
